| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B B Grill, T Tinghitella, C Hillemeier, J Grybosk. Increased intestinal clearance of alpha 1-antitrypsin in patients with alpha 1-antitrypsin deficiency. Journal of pediatric gastroenterology and nutrition. vol 2. issue 1. 1983-10-08. PMID:6604150. |
three of the alpha 1-at deficiency patients had values for c-alpha 1-at greater than the mean plus 3 sd of the control, but these were not in the range seen in patients with protein losing enteropathy. |
1983-10-08 |
2023-08-12 |
Not clear |
| I W Reimann, J C Frölic. Mechanism of antihypertensive action of ketanserin in man. British medical journal (Clinical research ed.). vol 287. issue 6389. 1983-09-23. PMID:6135489. |
steady state plasma ketanserin concentrations (mean 88 (sd 19) micrograms/1) and cardiovascular responses measured in five healthy volunteers showed that therapeutic doses of ketanserin significantly antagonised the alpha 1 receptor mediated increase in arterial blood pressure after treatment with methoxamine. |
1983-09-23 |
2023-08-12 |
human |
| K Spencer, E J Coombes, P J Woo. The measurement of amniotic fluid alpha 2 macroglobulin by fixed time kinetic immunoturbidimetry. Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie. vol 21. issue 3. 1983-07-08. PMID:6854223. |
the data indicates no significant variation of alpha 2 macroglobulin with gestational age and that the results in none neural tube defect pregnancies showed a narrow reference range with a mean of 1.67 mg/l and -/+ 2 sd range of 0.23--3.11 mg/l (99 percentile = 3.65 mg/l). |
1983-07-08 |
2023-08-12 |
Not clear |
| P K Liu, C C Chang, J E Trosko, D K Dube, G M Martin, L A Loe. Mammalian mutator mutant with an aphidicolin-resistant DNA polymerase alpha. Proceedings of the National Academy of Sciences of the United States of America. vol 80. issue 3. 1983-04-15. PMID:6402775. |
the apparent km for dctp with dna polymerase alpha is 1.0 +/- 0.4 microm (mean +/- sd) for the mutant enzyme. |
1983-04-15 |
2023-08-12 |
Not clear |
| J E Zerwekh, K Sakhaee, K Glass, C Y Pa. Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups. The Journal of clinical endocrinology and metabolism. vol 56. issue 2. 1983-03-11. PMID:6600460. |
in those who responded (n = 7), alpha increased from 0.36 +/- 0.05 to 0.49 +/- 0.08 (+/- sd; p less than 0.005) while no significant change was observed for the nonresponders (0.44 +/- 0.03 to 0.48 +/- 0.07). |
1983-03-11 |
2023-08-12 |
Not clear |
| B Wiman, T Nilsson, B Cedergre. Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen. Thrombosis research. vol 28. issue 2. 1983-02-25. PMID:6817454. |
the plasma concentration of npb-ap in healthy individuals was determined as 0.40 mumol/1 +/- 0.14 (sd), constituting 35% +/- 11 (sd) of the total plasma alpha 2-antiplasmin concentration. |
1983-02-25 |
2023-08-12 |
Not clear |
| R C Urtasun, H R Rabin, J Partingto. Human pharmacokinetics and toxicity of high-dose metronidazole administered orally and intravenously. Surgery. vol 93. issue 1 Pt 2. 1983-02-25. PMID:6849198. |
the mean (+/- sd) for alpha half-life was 1.2 +/- 1.3 hours, and that for the beta half-life was 9.8 +/- 5.9 hours. |
1983-02-25 |
2023-08-12 |
human |
| O Ylikorkala, T Osterman, I B Lindén, L Viinikk. The effect of age on circulating 6-keto-prostaglandin F1 alpha in humans. Prostaglandins, leukotrienes, and medicine. vol 9. issue 5. 1983-02-25. PMID:6960379. |
the 6-keto-pgf1 alpha concentrations (mean +/- sd) in subjects between 10-20 years of age were higher (126 +/- 63 pg/ml, n = 24) than the levels in subjects between 21-30 years of age (88 +/- 30 pg/ml, n = 16), or in subjects between 51-70 years of age (88 +/- 30 pg/ml, n = 17), whereas in subjects between 71-90 years of age, the 6-keto-pgf1 alpha levels 100 +/- 59 pg/ml, n = 36) did not differ from those in subjects under 20 years of age. |
1983-02-25 |
2023-08-12 |
human |
| D J Morgan, B B Koay, J D Paul. Plasma protein binding of etidocaine during pregnancy and labour. European journal of clinical pharmacology. vol 22. issue 5. 1982-12-02. PMID:7117359. |
etidocaine (1 microgram/ml) was found to bind avidly to a physiological concentration (74 mg/dl) of alpha 1-acid glycoprotein (alpha 1-agp) (7.23 +/- 0.64%, mean +/- sd, unbound). |
1982-12-02 |
2023-08-12 |
Not clear |
| P Hadjiisky, J Renais, L Sceba. A comparative study of the arterial tissue metabolism in atherosensitive and atheroresistant species. I. Comparison between rabbit and rat aortas. Paroi arterielle. vol 7. issue 4. 1982-12-02. PMID:7347389. |
the rat aortas (atheroresistant) had a better supply of aerobic oxidoreductases [linked to the pentose pathway (g6pd, 6pgd) as well as to the krebs cycle (sd, icd)], lipolytic enzymes (acid esterases, cholinesterase, lipase), lysosomal enzymes (acid ph/ase, aryl-sulf/ase - betaglu/ase), adpase - atpase - alk ph/ase alpha gpd and acid lipids. |
1982-12-02 |
2023-08-12 |
rat |
| E N Koullapis, K H Nicolaides, W P Collins, C H Rodeck, S Campbel. Plasma prostanoids in pregnancy-induced hypertension. British journal of obstetrics and gynaecology. vol 89. issue 8. 1982-10-21. PMID:6896650. |
the concentrations (pmol/l; means +/- sd) were pgfm 373 +/- 105, 6-oxo-pgf1 alpha 391 +/- 104 and t x b2 373 +/- 121. |
1982-10-21 |
2023-08-12 |
Not clear |
| b' H Rantala, K Finni, S Simil\\xc3\\xa. Alpha-1-antitrypsin: the PiM subtypes and serum concentrations in Finnish newborns. Human heredity. vol 32. issue 3. 1982-10-21. PMID:6980821.' |
the serum concentration (mean +/- sd) of alpha-1-antitrypsin (alpha 1-at) in the whole study group was 2.72 +/- 0.61 g/l. |
1982-10-21 |
2023-08-12 |
Not clear |
| J Teulon, T Anagnostopoulo. Proximal cell K+ activity: technical problems and dependence on plasma K+ concentration. The American journal of physiology. vol 243. issue 1. 1982-08-26. PMID:6283914. |
the control alpha ki value averaged 57.9 +/- 8.5 mm (mean +/- sd, n = 38) and the basolateral membrane potential was -70.4 +/- 5.8 mv. |
1982-08-26 |
2023-08-12 |
Not clear |
| O Ylikorkala, J Puolakka, L Viinikk. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans. American journal of obstetrics and gynecology. vol 142. issue 5. 1982-04-22. PMID:7036746. |
the plasma concentrations of 6-keto-pgf1 alpha in women with combined oral contraceptives (65.5 +/- 16.1 pg/ml, mean +/- sd) was lower (p less than 0.01) than that in the control subjects (77.4 +/- 26.4 pg/ml), whereas the use of combined oral contraceptives was associated with no changes in txb2 levels in plasma or serum, in women with progestogen-only oral contraceptives, the plasma levels of 6-keto-pgf1 alpha and txb2 were normal, but the capacity of the platelets to release txb2 during spontaneous clotting was decreased (113.6 +/- 77.6 ng/ml versus 179.9 +/- 81.9 ng/ml, p less than 0.05). |
1982-04-22 |
2023-08-12 |
human |
| R P Hartshorne, W A Catteral. Purification of the saxitoxin receptor of the sodium channel from rat brain. Proceedings of the National Academy of Sciences of the United States of America. vol 78. issue 7. 1981-12-21. PMID:6270687. |
two polypeptides, alpha (mr approximately equal to 270,000 +/- 10,000) and beta (mr approximately equal to 38,300 +/- 2000) (mean +/- sd) copurify with stx binding activity. |
1981-12-21 |
2023-08-12 |
rat |
| D Ylikorkala, L Viinikk. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion. Prostaglandins and medicine. vol 6. issue 4. 1981-11-24. PMID:7025068. |
the mean mass of added 6-keto-pgf1 alpha required to displace zero-point binding by 50 % was 55.6 +/- 5.1 pg (mean +/- sd, n = 10). |
1981-11-24 |
2023-08-12 |
human |
| S K Majumda. Chlormethiazole and utilization of vitamin B1 in chronic alcoholics. European journal of clinical pharmacology. vol 18. issue 4. 1981-02-26. PMID:7439259. |
mean +/- sd, of alpha etk improved pre-treatment level of 1.174 +/- 0.135 to 1.009 +/- 0.009 after treatment with thiamine. |
1981-02-26 |
2023-08-12 |
Not clear |
| J E Zerwekh, C Y Pak, R A Kaplan, J L McGuire, K Upchurch, N Breslau, R Johnso. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. The Journal of clinical endocrinology and metabolism. vol 51. issue 2. 1980-10-24. PMID:6893205. |
in eight patients with sarcoidosis, prednisolone treatment (50 mg/day for 8 days) produced a significant fall in serum 1,25(oh)2d [4.8 +/) 1.9 to 3.3 +/- 1.0 (sd) ng/dl; p less than 0.025], concomitant with a significant decrease in the fracitional intestinal ca absorption (alpha) from 0.58 +/- to 0.14 to 0.46 +/- 0.13 (+/- sd; p less than 0.005). |
1980-10-24 |
2023-08-12 |
Not clear |
| M Meyer, P Schei. Solubility of acetylene in human blood determined by mass spectrometry. Journal of applied physiology: respiratory, environmental and exercise physiology. vol 48. issue 6. 1980-08-25. PMID:7380699. |
at 37 degrees c, alpha c2h2 averaged 0.768 +/- 0.004 (sd) ml stpd.ml blood-1.atm-1, which is only slightly above the data from the literature. |
1980-08-25 |
2023-08-12 |
human |
| P A Routledge, A Barchowsky, T D Bjornsson, B B Kitchell, D G Shan. Lidocaine plasma protein binding. Clinical pharmacology and therapeutics. vol 27. issue 3. 1980-05-14. PMID:7357791. |
the percentage of unbound lidocaine varied from 19.9 to 38.8 (30.2 +/- 5, mean +/- sd) was inversely related to the concentration of alpha 1-acid glycoprotein (aag) in the plasma (r = -0.931, p less than 0.001). |
1980-05-14 |
2023-08-12 |
human |